Literature DB >> 22931458

Femtomolar inhibitors bind to 5'-methylthioadenosine nucleosidases with favorable enthalpy and entropy.

Keisha Thomas1, Antti M Haapalainen, Emmanuel S Burgos, Gary B Evans, Peter C Tyler, Shivali Gulab, Rong Guan, Vern L Schramm.   

Abstract

5'-Methylthioadenosine/S-adenosylhomocysteine nucleosidase (MTAN) catalyzes the hydrolytic cleavage of adenine from methylthioadenosine (MTA). Inhibitor design and synthesis informed by transition state analysis have developed femtomolar inhibitors for MTANs, among the most powerful known noncovalent enzyme inhibitors. Thermodynamic analyses of the inhibitor binding reveals a combination of highly favorable contributions from enthalpic (-24.7 to -4.0 kcal mol(-1)) and entropic (-10.0 to 6.4 kcal mol(-1)) interactions. Inhibitor binding to similar MTANs from different bacterial species gave distinct energetic contributions from similar catalytic sites. Thus, binding of four transition state analogues to EcMTAN and SeMTAN is driven primarily by enthalpy, while binding to VcMTAN is driven primarily by entropy. Human MTA phosphorylase (hMTAP) has a transition state structure closely related to that of the bacterial MTANs, and it binds tightly to some of the same transition state analogues. However, the thermodynamic signature of binding of an inhibitor to hMTAP differs completely from that with MTANs. We conclude that factors other than first-sphere catalytic residue contacts contribute to binding of inhibitors because the thermodynamic signature differs between bacterial species of the same enzyme.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22931458     DOI: 10.1021/bi3009938

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  Continuous Fluorescence Assays for Reactions Involving Adenine.

Authors:  Ross S Firestone; Scott A Cameron; Peter C Tyler; Rodrigo G Ducati; Adam Z Spitz; Vern L Schramm
Journal:  Anal Chem       Date:  2016-11-11       Impact factor: 6.986

2.  Crystal structures of the Helicobacter pylori MTAN enzyme reveal specific interactions between S-adenosylhomocysteine and the 5'-alkylthio binding subsite.

Authors:  Vidhi Mishra; Donald R Ronning
Journal:  Biochemistry       Date:  2012-11-20       Impact factor: 3.162

3.  Transition State Structure and Inhibition of Rv0091, a 5'-Deoxyadenosine/5'-methylthioadenosine Nucleosidase from Mycobacterium tuberculosis.

Authors:  Hilda A Namanja-Magliano; Christopher F Stratton; Vern L Schramm
Journal:  ACS Chem Biol       Date:  2016-04-08       Impact factor: 5.100

4.  Transition-State Analogues of Phenylethanolamine N-Methyltransferase.

Authors:  Niusha Mahmoodi; Rajesh K Harijan; Vern L Schramm
Journal:  J Am Chem Soc       Date:  2020-08-07       Impact factor: 15.419

5.  Neutron structures of the Helicobacter pylori 5'-methylthioadenosine nucleosidase highlight proton sharing and protonation states.

Authors:  Michael T Banco; Vidhi Mishra; Andreas Ostermann; Tobias E Schrader; Gary B Evans; Andrey Kovalevsky; Donald R Ronning
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-16       Impact factor: 11.205

6.  Active site and remote contributions to catalysis in methylthioadenosine nucleosidases.

Authors:  Keisha Thomas; Scott A Cameron; Steven C Almo; Emmanuel S Burgos; Shivali A Gulab; Vern L Schramm
Journal:  Biochemistry       Date:  2015-04-03       Impact factor: 3.162

Review 7.  Transition States, analogues, and drug development.

Authors:  Vern L Schramm
Journal:  ACS Chem Biol       Date:  2013-01-04       Impact factor: 5.100

8.  Salmonella enterica MTAN at 1.36 Å resolution: a structure-based design of tailored transition state analogs.

Authors:  Antti M Haapalainen; Keisha Thomas; Peter C Tyler; Gary B Evans; Steven C Almo; Vern L Schramm
Journal:  Structure       Date:  2013-05-16       Impact factor: 5.006

9.  Tight binding enantiomers of pre-clinical drug candidates.

Authors:  Gary B Evans; Scott A Cameron; Andreas Luxenburger; Rong Guan; Javier Suarez; Keisha Thomas; Vern L Schramm; Peter C Tyler
Journal:  Bioorg Med Chem       Date:  2015-07-30       Impact factor: 3.641

Review 10.  Enzymatic Transition States and Drug Design.

Authors:  Vern L Schramm
Journal:  Chem Rev       Date:  2018-10-18       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.